Axios360: A New Era In Cancer Innovation - Axios


Axios360: A New Era In Cancer Innovation

Chuck Kennedy

Axios Executive Editor Mike Allen and Executive Vice President Evan Ryan explore the innovations and solutions needed to end cancer as we know it. They discussed with:

  • The Honorable Joseph R. Biden Jr., 47th Vice President of the United States, Co-Chair, Biden Cancer Initiative
  • Dr. Jill Biden, Co-Chair, Biden Cancer Initiative
  • Mr. Mark Alles, CEO, Celgene Corporation
  • Ms. Stefanie Joho, Cancer Survivor and Advocate
  • Dr. Elizabeth Jaffee, Dana and Albert "Cubby" Broccoli Professor of Oncology, Deputy Director, Kimmel Cancer Center at Johns Hopkins
  • Mr. Sean Parker, Founder and Chairman of the Parker Institute for Cancer Immunotherapy

Guests line up inside Philadelphia's National Constitution Center. Chuck Kennedy

Mike Allen explains that today's program will illuminate what the future of cancer care could look like. Chuck Kennedy

Vice President Biden says we're at an inflection point in cancer research because of science and technology, but now it's time to break down the barriers that prevent sharing data. Chuck Kennedy

Joho, a cancer survivor whose life was saved by a clinical trial, explains the role patients play in cancer research. "Patients are partners of science - the science won't progress without us."Chuck Kennedy

"We can change cancer forever if we can put together all of these modalities - chemotherapy, radiotherapy, immunotherapy," Alles tells Evan Ryan. Chuck Kennedy

Parker tells Mike: "When you see this gap between what's possible and what's actually being done, that gap is your opportunity for disruption." Chuck Kennedy

Over 175 guests joined us in learning about what cancer research and care could become. Chuck Kennedy